tailieunhanh - Báo cáo khoa học: M1 – Peptidomimetics and Signal Transduction Inhibition

Cancer cells develop strong anti-apoptotic signaling pathways and therefore escape many therapeutic regimens. Recognizing this feature of cancer cells, we have focused on two approaches: dis-arming the cancer cell from its anti-apoptotic weaponry [1, 2] and applying strategies aimed at enhancing pro-apoptotic signa-ling pathways selectively in the cancer cell [3]. The first goal has been achieved by developing highly selective Aktstatins [1, 2] that inhibit PKB 100 times better than PKA or PKC. | Abstracts M1 - Peptidomimetics and Signal Transduction Inhibition M1-001 Tricking cancer cells to die A. Levitzki Unit of Cellular Signaling Department of Biological Chemistry The Alexander Silberman Institute of Life Sciences The Hebrew University of Jerusalem Jerusalem Israel. E-mail levitzki@ Cancer cells develop strong anti-apoptotic signaling pathways and therefore escape many therapeutic regimens. Recognizing this feature of cancer cells we have focused on two approaches disarming the cancer cell from its anti-apoptotic weaponry 1 2 and applying strategies aimed at enhancing pro-apoptotic signaling pathways selectively in the cancer cell 3 . The first goal has been achieved by developing highly selective Aktstatins 1 2 that inhibit PKB 100 times better than PKA or PKC. These inhibitors are highly non-toxic inhibit Akt PKB induced phosphorylation in cells and in vivo and are highly effective as anti-tumor agents in vivo. The complementary strategy is to enhance pro-apoptotic 520 Abstracts signaling pathways selectively in cancer cells 3 . One of the key elements is to induce in the targeted cancer cells signaling pathways that induce strong by-stander effects killing pretty fast not only the targeted cells but also the neighboring cancer cells that do not express the target a common situation in the heterogeneous human tumor. We have achieved this goal for tumors overexpressing the EGF receptors by targeting them with EGF guided non-viral vectors loaded with double stranded RNA. These dsRNA molecules are internalized by EGF receptor mediated endocytosis and kill only cells that over-express wild type EGFR and neighboring tumor cells co-growing with the targeted cells. Using this targeted polyIC we are able to cure mice bearing sizable intracranial human Glioblastma Multiforme GBM without harming normal brain tissue 4 . References 1. Reuveni H Livnah N Geiger T Klein S Ohne O Cohen I Benhar M Gellerman G Levitzki A. Toward a PKB inhibitor .

crossorigin="anonymous">
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.